(Q42635854)

4 November 2017

title

A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD. (English)

1 reference

4 November 2017

1 reference

1 reference

12

Tally Lerman-Sagie

1 reference

4 November 2017

3

Christopher Gillberg

1 reference

4 November 2017

1

Jan K Buitelaar

1 reference

4 November 2017

10

Philip Hazell

1 reference

ORCID Public Data File 2021

4 November 2017

1 reference

author name string

Marina Danckaerts

2

1 reference

4 November 2017

Alessandro Zuddas

4

1 reference

4 November 2017

Katja Becker

5

1 reference

4 November 2017

Manuel Bouvard

6

1 reference

4 November 2017

Jenny Fagan

7

1 reference

4 November 2017

Julia Gadoros

8

1 reference

4 November 2017

Valerie Harpin

9

1 reference

4 November 2017

Mats Johnson

11

1 reference

4 November 2017

Cesar A Soutullo

13

1 reference

4 November 2017

Tomasz Wolanczyk

14

1 reference

4 November 2017

Pal Zeiner

15

1 reference

4 November 2017

Daniel S Fouche

16

1 reference

4 November 2017

Judith Krikke-Workel

17

1 reference

4 November 2017

Shuyu Zhang

18

1 reference

4 November 2017

David Michelson

19

1 reference

4 November 2017

Stomoxetine International Study Group

20

1 reference

4 November 2017

publication date

1 August 2004

1 reference

European Child & Adolescent Psychiatry

4 November 2017

published in

1 reference

4 November 2017

volume

13

1 reference

4 November 2017

issue

4

1 reference

4 November 2017

page(s)

249-257

1 reference

Neuropsychological function in adults with attention-deficit hyperactivity disorder

4 November 2017

cites work

1 reference

12 December 2020

Validity of DSM-IVADHD subtypes in a nationally representative sample of Australian children and adolescents

1 reference

12 December 2020

Prevalence of attention deficit hyperactivity disorder in primary school children in Taiwan

1 reference

12 December 2020

Validity of DSM-IV subtypes of attention-deficit/hyperactivity disorder: a family study perspective

1 reference

12 December 2020

Attention-deficit hyperactivity disorder and hyperkinetic disorder

1 reference

12 December 2020

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

12 December 2020

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences

1 reference

12 December 2020

Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study

1 reference

12 December 2020

Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments

1 reference

12 December 2020

Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users

1 reference

12 December 2020

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

1 reference

12 December 2020

Clinical guidelines for hyperkinetic disorder. European Society for Child and Adolescent Psychiatry

1 reference

12 December 2020

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

1 reference

12 December 2020

[Study of the prevalence of the attention deficit hyperactivity disorder in ten-year-old children living in the Valencia metropolitan area]

1 reference

12 December 2020

ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments

1 reference

12 December 2020

The comorbidity of ADHD in the general population of Swedish school-age children.

1 reference

12 December 2020

Test-retest reliability of the Multidimensional Anxiety Scale for Children

1 reference

12 December 2020

Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates

1 reference

12 December 2020

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Canadian-French, German and UK versions of the Child Health Questionnaire: methodology and preliminary item scaling results

1 reference

12 December 2020

Appropriateness of psychostimulant prescription to children: theoretical and empirical perspectives

1 reference

12 December 2020

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

12 December 2020

1 reference

12 December 2020

Stimulant treatment in Maryland public schools

1 reference

12 December 2020

Neurobiology of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

12 December 2020

10.1007/S00787-004-0401-3

Identifiers

DOI

1 reference

Dimensions Publication ID

4 November 2017

1037321261

0 references

1 reference